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Background. The live oral rotavirus (RV) vaccines have shown a reduced efficacy in Africa. Recent in vitro stud-
ies have shown binding of the RV surface protein (VP4) to histo–blood group antigens (HBGAs) in an RV genotype–
dependent manner, suggesting them to be putative receptors for RV. The diversity of HBGA phenotypes in different
ethnic populations, combined with prevalence/absence of specific RV genotypes, led us to hypothesize whether the
genetic variations in HBGAs in a population limit susceptibility to certain RV genotypes, plausibly leading to re-
duced vaccine efficacy.
Methods. Association between HBGAs status and susceptibility to RV P genotypes was investigated in children
in Burkina Faso and Nicaragua. In total, 242 children with diarrhea in Burkina Faso and Nicaragua were investigated,
93 of whom were RV positive.
Results. In Burkina Faso, the P[8] RV strains (n = 27) infected only Lewis- and secretor-positive children (27/27;
P < .0001), but no Lewis-negative children. In contrast, the P[6] strains (n = 27) infected predominantly Lewis-
negative children (n = 18; P < .0001) but also Lewis-positive children, irrespective of their secretor status. The results
from Nicaragua confirmed that all P[8]-infected children (n = 22) were secretor Lewis positive.
Conclusions. As VP4 of genotype P[8] is a component of current RV vaccines, our finding that Lewis-negative
children are resistant to P[8] strains provides a plausible explanation for the reduced vaccine efficacy in populations
with a high percentage of Lewis-negative individuals, such as in Africa. Furthermore, our findings provide a plausible
explanation as to why P[6] RV strains are more common in Africa.
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Rotavirus (RV) is the leading cause of severe acute
gastroenteritis in infants and young children and is re-
sponsible for approximately 450 000 deaths annually,
the majority occurring in children from low- and
middle-income countries, with an especially high bur-
den in sub-Saharan Africa [1, 2]. The World Health Or-
ganization recommends inclusion of RV vaccines in the
national immunization program of countries highly af-
fected by RV. Currently, 2 vaccines, Rotarix and Rota-
Teq, are licensed and available in many countries.
Although the vaccines have demonstrated high efficacy
in industrialized countries, vaccine trials from sub-
Saharan Africa have shown reduced efficacy [3, 4].
The reasons for this are yet unknown, but malnutrition,
concomitant infections, RV strain diversity, and host
factors have been proposed. The genetic makeup of
Received 7 May 2014; accepted 15 July 2014; electronically published 5 August
2014.
aJ. N., S. S., and F. B. contributed equally to this work.
Correspondence: Lennart Svensson, PhD, Division of Molecular Virology, Depart-
ment of Clinical and Experimental Medicine, Linköping University, 58183 Linköping,
Sweden (lennart.t.svensson@liu.se).
Clinical Infectious Diseases® 2014;59(11):1567–73
© The Author 2014. Published by Oxford University Press on behalf of the Infectious
Diseases Society of America. All rights reserved. For Permissions, please e-mail:
journals.permissions@oup.com.
DOI: 10.1093/cid/ciu633
Host Genetics and Rotavirus Infection • CID 2014:59 (1 December) • 1567
RV strains circulating in Africa is different from those in high-
income countries. In addition to a higher degree of animal or
animal-derived strains, the genotype P[6] is also relatively
more prevalent in Africa than in Europe and North America
[5–7].
The VP4 (P genotype) protein mediates RV attachment and
entry into the mature enterocytes through its glycan binding do-
main, VP8* [8]. Previous in vitro studies have shown RV infec-
tion to be sialic acid dependent. Animal rotaviruses recognize
terminal sialic acids of the host cell (sensitive to sialidase), where-
as many human rotaviruses recognize internal sialic acid residues
(insensitive to sialidase) [9, 10]. However, an association of these
specificities for susceptibility to RV infection in vivo has not been
observed to date. Recent in vitro studies, using various glycan
binding assays, have demonstrated that the most common
human RVs recognize human histo–blood group antigens
(HBGAs) in a P genotype–specific manner [9, 11–13]. The type
1 chain HBGAs are primarily expressed in the gut and present on
most epithelial cells in the intestinal and respiratory tracts as well
as in secretions such as saliva. These glycans are recognized as
susceptibility and cell attachment factors for several enteric path-
ogens such as Helicobacter pylori and norovirus [14–16]. For the
biosynthesis of HBGAs, the secretor gene (FUT2) encoding en-
zyme transfers fucose into an α1-2 linkage to the terminal Gal of
the type 1 chain precursor (Galβ3GlcNAcβ), making the H type 1
antigen (Fucα2Galβ3GlcNAcβ) (Figure 1). Interestingly, a recent
in vivo study suggested the secretor-positive genotype to confer
susceptibility to P[8] RV genotypes [17]. The Lewis gene
(FUT3)–coded enzyme, on the other hand, transfers fucose
into an α1-4 linkage to the type 1 chain precursor or to the H
type 1 antigen, generating Lewis a (Galβ3[Fucα4]GlcNAcβ) or
Lewis b antigens (Fucα2Galβ3[Fucα4]GlcNAcβ), respectively
(Figure 1). The expression of H type 1 and Lewis HBGAs is
thus genetically determined based on polymorphisms in the
FUT2 and FUT3 genes. The frequency of these polymorphisms
varies markedly between different ethnic populations; for in-
stance, only 4%–6% of white populations do not express Lewis
antigens, whereas the prevalence of this Lewis-negative pheno-
type can reach >30% in certain African and Latin American
populations [18–20].
Here, we report that the Lewis (FUT3) and secretor (FUT2)
genes mediate susceptibility for symptomatic RV infection, with
both Lewis-negative and secretor-negative phenotypes being
strong restriction factors for RV genotype P[8] infections. We
further show that P[6] RVs mainly infect Lewis-negative chil-
dren, a phenotype more common in African populations, pro-
viding a plausible explanation for the relatively high frequency
of the P[6] genotype in Africa. Moreover, we hypothesize that
the resistance to P[8] strains in Lewis-negative children could be
an important contributing factor to the modest RV vaccine ef-
ficacy in sub-Saharan Africa.
MATERIALS AND METHODS
Study Population and Sample Collection
Fecal and saliva samples analyzed for association of RV P geno-
types and host HBGA phenotypes in children with diarrhea were
collected from 2 different populations, Burkina Faso in West
Africa and Nicaragua in Central America. The RV-positive
samples from Burkina Faso included in this study (n = 59)
were collected during the RV season (December 2009–March
2010) at Saint Camille Medical Center CERBA/LABIOGENE
in Ouagadougou, Burkina Faso [21]. In brief, stools, saliva, and
buccal swabs were collected from children <5 years of age who
presented with diarrheal illness. The G and P genotypes of the
infecting RVs were determined by multiplex polymerase chain
reaction (PCR) and/or sequencing as described previously [7].
The 59 RV strains represent all RV-positive samples among the
208 children included in the study. The study protocol was ap-
proved by the institutional ethics committee of Saint Camille
Medical Center (2012CR/X-25/i135).
In addition to the Burkina Faso material, a total of 34 chil-
dren from León, Nicaragua (with RV infection confirmed by
Figure 1. Biosynthetic pathways of histo–blood group antigens. The pre-
cursors from type 1/2 chain are considered. The antigen names (in gray
boxes), genetic loci of glycosyltransferases (in italics), and the glycosidic
linkages (in solid lines) are separated by a forward slash (/) to specify the
pathway for different chains. The FUT2 and the FUT3 genetic loci driving
the biosynthesis of the secretor (Se) and the Lewis (Le) antigens, respec-
tively, are highlighted (in bold).
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enzyme-linked immunosorbent assay [ELISA] and PCR in pre-
vious studies) were also included. These children were previous-
ly enrolled in studies of childhood diarrhea etiologies involving
>1000 diarrheic cases from the community, primary care clin-
ics, and the hospital in León that were carried out in 2005 [22],
2008–2009, and 2010–2011. Saliva samples from the children
included in the present study (n = 34) were collected by a
nurse during home visits. Prior to sampling, informed consent
was signed by a parent or legal guardian. All children were
<5 years of age when initially examined for RV. This study
was approved by the local ethical committee for biomedical
research (Acta No. 18, 2012). The G and P types of the RV-
positive samples, if not previously determined, were assessed
by multiplex PCR and confirmed with sequencing as described
previously [22].
Saliva Phenotyping Assay
A detailed description of the saliva phenotyping assay is avail-
able in the Supplementary Materials and Methods 1. In brief,
presence of the HBGAs (A, B, Lewis a, and Lewis b) in saliva
was determined by ELISA assay, as previously described [20].
A subset of saliva samples were also investigated with Ulex euro-
paeus agglutinin (UEA-I), which recognizes Fucα1-2Gal-R pre-
sent in saliva of secretors, with an ELISA assay as previously
described [20].
Genotypic Characterization of the FUT3 Gene From
Children in Burkina Faso
To confirm the Lewis phenotype, DNAwas extracted from buc-
cal cells collected from a subset of children from Burkina Faso
(n = 35) with Whatman OmniSwab (GE Healthcare, Uppsala,
Sweden), and the coding region of the FUT3 gene was se-
quenced. All Lewis-negative children from whom buccal
swabs were available were included (n = 31), together with 4
randomly selected Lewis-positive children from Burkina Faso.
MagAttract DNA Mini M48 kit (Qiagen, Hilden, Germany)
was used for extraction, and DNA was stored at −20°C for sub-
sequent sequencing.
The messenger RNA sequence of the FUT3 gene (accession
number NM_000149) was obtained from the University of Cal-
ifornia, Santa Cruz Genome browser (available at: http://genome.
ucsc.edu). ExonPrimer (available at: http://ihg.gsf.de/ihg/Exon
Primer.html) was used to design primers to cover the coding se-
quence (CDS). These primers, covering the FUT3 CDS region for
exon 3, were designed in 4 fragments; for the FUT3_Ex3_2 frag-
ment, the pair (EL-3s and III-l2as) was adapted from Elmgren
et al [23]. The sequences of the PCR primers for FUT3 are
listed in Supplementary Table 1, together with detailed descrip-
tion of the analytical procedure (Supplementary Materials and
Methods 2).
Statistical Analysis
Fisher exact test and unadjusted odds ratios were used to com-
pare frequencies of qualitative variables between dependent
groups using GraphPad Prism version 5.0 (GraphPad Software,
San Diego, California). Differences were considered to be statisti-
cally significant when the level of 2-tailed significance was <.05.
RESULTS
Lewis-Negative Children Were Resistant to P[8] RV
Strains in Burkina Faso
In a previous study, we observed a high prevalence of the Lewis-
negative phenotype (Lea
−b−) in Burkina Faso [20]. Among the
208 children with diarrhea enrolled, the phenotypic HBGA dis-
tribution was Lea
−b+ (54%), Lea
+b− (14%), and Lea
−b− (32%), with
80% and 20% being secretors and nonsecretors, respectively. To
determine the association between HBGA and susceptibility to
RV infections and genotypes, 59 RV-positive children infected
with P[4] (n = 2), P[6] (n = 27), P[8] (n = 27), and P[6]/[P8]
(n = 3) were investigated. Whereas the frequency of the Lewis-
negative children was almost identical between the population
Table 1. Association Between Lewis Phenotype and Infecting P Genotype Among Rotavirus-Positive Children in Burkina Faso
Lewis
Phenotype
Lewis Phenotype in the
Study Population,
n = 208 (%)
Lewis Phenotype
in RV Positives,
n = 59a (%)
P[6] P[8]
RV P[6],












−b+ n = 113 (54) 38 (64) 6 (22) 0.2 (.1–.5) .0004 27 (100)d NA <.0001
Lea
−b− n = 66 (32) 18 (31) 18 (67) 5.5 (2.3–13.2) <.0001 0 (0) 0.0 (NA) <.0001
Lea
+b− n = 29 (14) 3 (5) 3 (11) 0.7 (.2–2.7) 1.0 0 (0) 0.0 (NA) .0176
Abbreviations: CI, confidence interval; Le, Lewis; NA, not applicable; RV, rotavirus.
a Two P[4] RV infections were found in Lea
−b+ children, and 3 mixed P[6]/P[8] infections were found in Lea
−b+ children. In the table, only P[6] or P[8] single-genotype
infections are presented.
b Unadjusted odds ratio.
c Fisher exact test with 2-tailed significance compared with Lewis phenotype distribution in study population.
d One P[8]-infected Lewis b–positive, Ulex europaeus agglutinin I–negative child was classified as a secretor based on FUT2 genotyping.
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and the RV-infected groups (32% vs 31%; Table 1), none of the
RV-positive, Lewis-negative children were infected with P[8]
RV genotypes (Table 1; P < .0001). P[8] RV strains (n = 27)
were only found in Lewis-positive children, who were all secre-
tors (27/27; P < .0001; Tables 1 and 2). The 2 P[4] RV genotypes
as well as the 3 mixed P[6]/P[8] RV infections were observed
only in children with the Lewis- and secretor-positive pheno-
type (Lea
−b+).
RV Strains of Genotype P[6] Infected Mainly Lewis-Negative
Children in Burkina Faso
Two-thirds of the P[6] RV genotypes infected Lewis-negative
children (18/27; odds ratio, 5.5; P < .0001; Table 1). The P[6]
RV strains were significantly more frequent in Lewis-negative
children, but independent of the secretor status as determined
by Ulex europeus binding to saliva or presence of Lewis antigens
(Table 2). Among the secretor-positive children, P[6] RVs were
observed more often in children of blood type O compared with
P[8] RVs (61% vs 23%; P = .015), while being less frequent in
children of blood type A (17% vs 31%; P > .05) and blood
type B (17% vs 46%; P > .05), compared with P[8] RVs.
Sequencing of the FUT3 Open-Reading Frame of Lewis-Negative
Children Confirmed the Saliva Phenotypes
To confirm the Lewis-negative phenotype, the entire coding se-
quence of the FUT3 gene was sequenced from 31 children who
were Lewis-negative by ELISA. Thirty of 31 were genotypically
confirmed as Lewis-negative for previously published alleles
(available at: http://www.ncbi.nlm.nih.gov/projects/gv/mhc/
xslcgi.cgi?cmd=bgmut/systems).
None of those individuals was homozygous for only a single
allele. In total, 15 Lewis-negative alleles were identified (Supple-
mentary Table 2), and the 3 dominating were the 59T>G;
508G>A; 858A>G, the 13G>A; 484G>A; 667G>A and the
202T>C; 314C>T alleles, corresponding to 18 (30%), 8 (13%),
and 6 (10%) of the alleles, respectively. One RV-negative child
was phenotyped as Lewis negative but was by sequencing het-
erozygous, with only 1 known negative FUT3 allele (59T>G,
508G>A, 858A>G); the other had a point mutation of unknown
significance and could thus not be completely explained.
Sequencing was performed for 4 Lewis-positive children
(3 Lea
+b− and 1 Lea
−b+), and they were genetically heterozygous
with only 1 Lewis-negative allele.
P[8] RVs Infected Only Lewis- and Secretor-Positive
Children in Nicaragua
To confirm that the host genetic pattern observed in Burkina
Faso was not limited to a particular ethnic population in Africa,
saliva samples from RV-positive children in Nicaragua were
also collected and analyzed. The Lewis distribution in RV-
positive children was Lea
−b+ (94%), Lea
+b− (0%), and Lea
−b− (6%),
The P genotype distribution of the 34 RV-positive samples was
P[4] (n = 7), P[6] (n = 4), P[8] (n = 22), and P[4]/P[6]/P[8] mix
(n = 1). RV of genotype P[8] (n = 22) was only observed in
Lewis- and secretor-positive (Lea
−b+ children) and not in
Lewis-negative children, nor in Lewis-positive nonsecretors
(Supplementary Table 3). Also, RV of genotype P[4] was only
observed in Lewis- and secretor-positive children, but their
small number warrants a cautious interpretation (Supplementa-
ry Table 3). Furthermore, as in Burkina Faso, the Lewis-negative
children were infected only with genotype P[6] (Supplementary
Table 3); however, the number of Lewis-negative children in this
cohort (n = 2) was too small to draw any conclusions. The 2
Lewis-negative children infected with RV P[6] were also nonse-
cretors as determined by the UEA-I lectin. Even though the
prevalence of the Lewis-positive no-secretor (Lea
+b−) phenotype
is low (<5%) in Nicaragua [24], no such child was infected with
any RV genotype (Supplementary Table 3).
Table 2. Association Between Rotavirus P Genotypes to Lewis and Secretor Status in Burkina Faso
Phenotype
Study Population
(n = 208) (%)
P[6] P[8]
RV P[6]
(n = 27) (%)
Odds Ratio
(95% CI)a P Value
RV P[8]
(n = 27) (%)
Odds Ratio
(95% CI)a P Value
Lewis positive n = 142 (68) n = 9 (33) 0.2 (.08–.4) <.0001b n = 27 (100) NA <.0001b
Secretor n = 113 (80) 6 (67) 0.5 (.1–2.1) .389c 27d (100) NA .0013c
Nonsecretor n = 29 (20) 3 (33) 2.1 (.5–8.8) .389c 0 (0) 0.0 (NA) .0013c
Lewis negative n = 66 (32) 18 (67) 5.5 (2.3–13.2) <.0001b 0 (0) 0.0 (NA) <.0001b
Secretor n = 52 (79) 12 (67) 0.4 (.1–1.4) .180c 0 (0) NA NA
Nonsecretor n = 14 (21) 6 (33) 2.5 (.7–8.6) .180c 0 (0) NA NA
Abbreviations: CI, confidence interval; NA, not applicable; RV, rotavirus.
a Unadjusted odds ratio.
b Fisher exact test with 2-tailed significance, compared with Lewis phenotype distribution in the study population.
c Fisher exact test with 2-tailed significance, comparing secretor vs nonsecretor, stratified by Lewis positive or Lewis negative, respectively.
d One P[8]-infected Lewis b–positive, Ulex europaeus agglutinin I–negative child was classified as a secretor based on FUT2 genotyping.
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DISCUSSION
It was recently described that human RVs recognize HBGAs [9,
11–13]. In this study from Burkina Faso and Nicaragua, we
found that P[8] RVs infected exclusively Lewis- and secretor-
positive children. In contrast, P[6] RV strains infected mainly
Lewis-negative children, independent of their secretor status.
Our observation that RV P[6] genotypes preferably infected
Lewis-negative children is complementary to the in vitro find-
ings by Huang et al [12] showing binding of recombinant VP8*
protein of P[6] genotypes to synthetic H type 1 antigen (present
in epithelial surfaces of Lewis-negative secretors), but not to the
Lewis b antigen (present in the epithelial surfaces of Lewis-
positive secretors). In our study, we also observed P[6] RV
strains infecting 6 Lewis-negative nonsecretors, suggesting
that the type 1 chain precursor could also act as a mediating fac-
tor for susceptibility to the P[6] genotypes. This antigen was not
tested for its binding capacity by Huang et al [12]. The core
structure of the type 1 chain glycans, Galβ3GlcNAc, may thus
be essential for cell-mediated binding and entry, or more im-
portant, for productive infection by P[6] strains. However, we
also observed that 33% of all P[6] infections were found in
Lewis-positive children. It is important to note that all type 1
chain precursors are not always entirely converted into Lewis
a, H, or Lewis b antigens by the fucosyltransferase encoded by
the FUT3 and FUT2 genes; thus, core structures may coexist to-
gether with the ABH and Lewis HBGAs [25, 26], acting as pos-
sible attachment factors. Interestingly, a recent in vivo study
from Vietnam reported low Lewis b expression in P[6]-infected
children [27], indicative of a lower conversion rate and higher
presence of such core structures.
We further observed that Lewis-negative children were infected
neither with P[8] nor with P[4] RV; however, the number of P[4]
genotypes in this study were few, thus warranting careful inter-
pretation. All P[8] and P[4] RVs infected Lewis- and secretor-
positive children. Of note, among P[8]-infected children, one
child had, in addition to Lewis b, high levels of Lewis a and was
UEA-I lectin negative. Nucleotide sequencing of the FUT2 gene
for this child showed a heterozygous secretor genotype and was
thus considered to be a secretor. Huang et al [12] showed an in
vitro binding of recombinant VP8* proteins of the P[8] and P
[4] genotypes to both H type 1 and Lewis b antigens, but not
to Lewis a, which partially agrees with our findings. However,
in our study, no Lewis-negative secretor (expressing the H type
1 antigen) was infected with P[8] strains, suggesting that presence
of H type 1 antigen was not sufficient for establishing a P[8] ge-
notype–specific symptomatic infection. Our results thus indicate
that the additional α1-4 linked fucose on the H type 1 antigen
(making the Lewis b antigen) is important for susceptibility of ge-
notype P[8]. Interestingly, Huang et al [12] observed that purified
triple layer particles of the Wa strain (P[8] genotype) exhibited in
vitro binding to Lewis-positive saliva but not to Lewis-negative
saliva of secretors, which is in line with our findings.
Moreover, our in vivo observations together with previous
binding studies [12] favor that RV P[4] and P[8] genotypes use
similar cell attachment factors; although the number of P[4]
genotype infections in this study were few, thus further studies
are warranted. As previously suggested [12], this would explain
why these 2 P genotypes occur in a cyclic pattern in white pop-
ulations in Europe and North America having a high prevalence
of individuals with the Lewis- and secretor-positive phenotype.
Recent in vivo studies from France and Vietnam observed
that RVs of genotype P[8] infected only secretor-positive chil-
dren [17, 27]. Both studies focused on the role of secretor status
in RV infection. The vast majority of secretor-positive individ-
uals among white populations express the Lewis b antigen.
However, in Burkina Faso, which has a much higher percentage
of Lewis-negative individuals; we could study the role of both
FUT2 and FUT3 genes in relation to RV strain–specific host
susceptibility and thus suggest the importance of functionality
of both these genes in susceptibility to P[8] RV infections.
Our observation that only P[6] but not P[8]/P[4] genotypes in-
fected Lewis-negative children could further provide an explana-
tion to why the P[6] genotype is observed in the vast majority of
neonatal RV infections [28, 29], but rarely in older children [6, 30].
Support for this hypothesis comes from previous studies report-
ing that the expression of Lewis antigens on the erythrocytes
develop with age and that young children usually are Lewis neg-
ative until 1–2 months of age, after which the Lewis antigens
are expressed [31]. Thus, neonatal children having a Lewis-
negative phenotype could be susceptible to RV P[6] genotypes,
but not to genotypes P[4] and P[8]. However, it is important to
note that these studies were performed on erythrocytes, which do
not directly correspond to Lewis antigens present in the intestinal
tract. Glycosphingolipids carrying the HBGA type 1 chain ABH
and Lewis antigens are enriched in fetal gut epithelium and inme-
conium of neonates [32]. The type 1 chain precursor (Galβ3Glc-
NAc) is typically present in high amounts in neonatal gut
together with all the HBGAs on glycolipids carrying the ABH, se-
cretor, and Lewis gene end products [26].This pattern contrasts to
that of the adult small intestine, where the type 1 chain precursor
is usually not detectable and has only been described in 1 Lewis-
and secretor-negative individual [33] and in a proximal resection
of jejunum taken from a patient with gastric cancer [25]. Al-
though only minor structural changes of fucosylated glycosphin-
golipids occur along the villus axis of an adult intestine [34], little
is known about the cell-specific, temporal, and longitudinal
changes of HBGAs in intestinal tissues in early childhood [35],
especially in relation to changes in the gut microflora [36]. It is
important to note that discrepancies between saliva and gut
HBGA expression can occur, for example, due to infection with
pathogens such as H. pylori as recently reported [37].
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The fact that the Lewis-negative phenotype is more common
in many African populations [19, 20]may explain why P[6] RV
infections are much more common in Africa than in white pop-
ulations in Europe and North America where the Lewis-
negative phenotype is rare [18, 23]. In view of our findings,
host genetic susceptibility could also have implications for vac-
cine efficacy. The P[8] genotype is a major component of 2 li-
censed RV vaccines whose efficacy has been proven modest in
Africa compared with other regions [3, 4], with African popula-
tions having a high frequency of Lewis-negative individuals [19,
20]. Because a productive infection by the live attenuated vac-
cines would stimulate an immune response, it is reasonable to
suggest vaccine efficacy to be lower for Lewis-negative individ-
uals. Moreover, as expression of HBGAs is developmentally reg-
ulated, it is important to consider both the composition of the
vaccine strain and the optimal age of immunization.
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